Clinical Trials
Showing of 41 results
Novel Gene Therapy Treatment for Glioblastoma Moves Forward at UH Seidman Cancer Center
Phase II clinical trial of promising approach soon to begin at UH Seidman and second site at the NIH Clinical Center - Innovations in Cancer | Winter 2021
New Immunotherapy Center at UH Seidman Cancer Center Sets the Stage for Solutions
Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021
UH Rainbow Provides Continuing Leadership on Neonatal Abstinence Syndrome
Work on statewide quality improvement collaborative leads to further decreases in length of stay for infants exposed to opioids in utero - Innovations in Pediatrics | Winter 2021
Sally Ibrahim, M.D. Leads New Study in Sleep for Children with Downs Syndrome
UH Research & Education Update |November 2020
UH Seidman Cancer Center Opens New Trial with PVSRIPO, a Viral-based Immunotherapy in Combination with Pembrolizumab for Patients with Recurrent GBM
The two therapies may be able to generate a potent and specific anti-tumor response in rGBM patients, given their different but complimentary mechanisms of action - Innovations in Cancer | Fall 2020
UH Seidman Cancer Center Leads $7.3 Million Multi-Site Trial of Relapse Prevention in ALL
Survival at one year post-stem cell transplant is 100% - Innovations in Cancer | Fall 2020
University Hospitals and CWRU Announce Study of AstraZeneca’s COVID-19 Vaccine Candidate
Phase 3 clinical trial of AZD1222 uses a replication-deficient chimpanzee viral vector - News Release
Improving Functional Outcomes after Intracerebral Hemorrhage
MIND study explores safety and efficacy of minimally invasive hematoma evacuation with Artemis device - Innovations in Neurology & Neurosurgery | Fall 2020